By Karin McCay| email
Edited by Kristin Beerman | email
LUBBOCK, TX (KCBD) – New research from Africa indicates a new gel has the potential to save millions of women from infection with the AIDS virus. Scientists say the vaginal gel containing an anti-AIDS medication cut the HIV infection rate among women by 39% and researchers are hopeful that another combination of drugs may do even better than that.
"It represents a major victory for the field of HIV prevention research," said Dr. Ward Cates, with Family Health International.
The two year trial on almost 900 women also found that the gel cut the rate of infections with genital Herpes by 51%, which is important because they say herpes infections can increase the risk for future infections with the AIDS virus. The drug in the gel is called Tenovifir, which is usually given to AIDS patients in pill form, but the drug maker says as a preventive measure and it will make the gel available free to poor nations.
©2010 KCBD NewsChannel 11. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.